PTC Therapeutics wins FDA nod for gene therapy
PTC Therapeutics (NASDAQ:PTCT) has received FDA approval for its gene replacement therapy Kebilidi for the treatment of ...
Trump set to deepen tech Cold War with China
The containment policy set in the first Trump administration and continued under President Biden will get a harder edge, ...
Center on Budget and Policy Priorities5h
Premium Tax Credit Improvements Must Be Extended to Prevent Steep Rise in Health Care Costs
Improvements to premium tax credits, enacted in the American Rescue Plan and extended by the Inflation Reduction Act, have ...
PTC Therapeutics’ AADC deficiency gene therapy granted FDA approval
PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...
Reuters15h
Many long COVID patients adjust to slim recovery odds as world moves on
Healthcare & Pharmaceuticalscategory More than 800 million adults have diabetes globally, many untreated, study suggests 3:56 ...
Reuters17h
US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder
PTC Therapeutics' gene therapy is already approved in the European ... alongside the dollar on Thursday as investors bet that ...